The Costs of Immunobiological Losses in Basic Health Units

Abstract

Abstract:The main objective is to describe the losses of the immunobiologicals per the type and to assess the financial costs of the mentioned losses in the municipality of Petrolina in the year 2013. Method: descriptive and quantitative documentary research. We analyzed the suspected immunobiological reports between January and December 2013. The Mann-Whitney and Kruskal Wallis tests were applied at the significance level of 5%, 95% confidence interval, using the program Stata 12.0. Approved by the Ethics and Research Committee of the University of Pernambuco CAAE 34873214.1.0000.5207. Results: a loss of 10,439 vaccine doses was observed, with a total financial cost of R $ 72,864.2. Viral vaccines had the highest losses in the study (55.4%), with 6,373 doses lost and a total cost of R $ 45,007.7. Higher financial impacts were caused by influenza followed by pneumococcal 10. Conclusion: losses in the period were significant, both in percentage terms and in monetary values representing costs for health systems.